APA (7th ed.) Citation

Wong, A. K. Q., Khan, S. R., Hadi, D. K., Breadner, D., & Vincent, M. D. (2026). Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions. Current Oncology, 31(1), 55. https://doi.org/10.3390/curroncol33010055

Chicago Style (17th ed.) Citation

Wong, Angel Kwan Qi, Saqib Raza Khan, Danial Khan Hadi, Daniel Breadner, and Mark David Vincent. "Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions." Current Oncology 31, no. 1 (2026): 55. https://doi.org/10.3390/curroncol33010055.

MLA (9th ed.) Citation

Wong, Angel Kwan Qi, et al. "Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions." Current Oncology, vol. 31, no. 1, 2026, p. 55, https://doi.org/10.3390/curroncol33010055.